MA38338B1 - Procédé de fabrication de vortioxétine - Google Patents

Procédé de fabrication de vortioxétine

Info

Publication number
MA38338B1
MA38338B1 MA38338A MA38338A MA38338B1 MA 38338 B1 MA38338 B1 MA 38338B1 MA 38338 A MA38338 A MA 38338A MA 38338 A MA38338 A MA 38338A MA 38338 B1 MA38338 B1 MA 38338B1
Authority
MA
Morocco
Prior art keywords
vortioxetine
manufacturing
formula
dimethylthiophenol
decomplexation
Prior art date
Application number
MA38338A
Other languages
English (en)
French (fr)
Other versions
MA38338A1 (fr
Inventor
Thomas Ruhland
Kim Lasse Christensen
Original Assignee
H Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck As filed Critical H Lundbeck As
Publication of MA38338A1 publication Critical patent/MA38338A1/fr
Publication of MA38338B1 publication Critical patent/MA38338B1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02Iron compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Cephalosporin Compounds (AREA)
MA38338A 2013-02-22 2014-02-20 Procédé de fabrication de vortioxétine MA38338B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA201300104 2013-02-22
PCT/EP2014/053313 WO2014128207A1 (en) 2013-02-22 2014-02-20 Vortioxetine manufacturing process

Publications (2)

Publication Number Publication Date
MA38338A1 MA38338A1 (fr) 2016-09-30
MA38338B1 true MA38338B1 (fr) 2018-10-31

Family

ID=59215387

Family Applications (1)

Application Number Title Priority Date Filing Date
MA38338A MA38338B1 (fr) 2013-02-22 2014-02-20 Procédé de fabrication de vortioxétine

Country Status (37)

Country Link
US (1) US9353073B2 (cg-RX-API-DMAC7.html)
EP (1) EP2958903B1 (cg-RX-API-DMAC7.html)
JP (1) JP6464098B2 (cg-RX-API-DMAC7.html)
KR (1) KR102230628B1 (cg-RX-API-DMAC7.html)
CN (1) CN104995181B (cg-RX-API-DMAC7.html)
AP (1) AP2015008640A0 (cg-RX-API-DMAC7.html)
AU (1) AU2014220735B2 (cg-RX-API-DMAC7.html)
BR (1) BR112015019268B1 (cg-RX-API-DMAC7.html)
CA (1) CA2901821A1 (cg-RX-API-DMAC7.html)
CL (1) CL2015002309A1 (cg-RX-API-DMAC7.html)
CR (1) CR20150423A (cg-RX-API-DMAC7.html)
CY (1) CY1118883T1 (cg-RX-API-DMAC7.html)
DK (1) DK2958903T3 (cg-RX-API-DMAC7.html)
DO (1) DOP2015000187A (cg-RX-API-DMAC7.html)
EA (1) EA027756B1 (cg-RX-API-DMAC7.html)
ES (1) ES2625380T3 (cg-RX-API-DMAC7.html)
GE (1) GEP201706749B (cg-RX-API-DMAC7.html)
HR (1) HRP20170607T1 (cg-RX-API-DMAC7.html)
IL (1) IL240501B (cg-RX-API-DMAC7.html)
LT (1) LT2958903T (cg-RX-API-DMAC7.html)
MA (1) MA38338B1 (cg-RX-API-DMAC7.html)
ME (1) ME02671B (cg-RX-API-DMAC7.html)
MX (1) MX362355B (cg-RX-API-DMAC7.html)
MY (1) MY172337A (cg-RX-API-DMAC7.html)
PE (1) PE20151589A1 (cg-RX-API-DMAC7.html)
PH (1) PH12015501807B1 (cg-RX-API-DMAC7.html)
PL (1) PL2958903T3 (cg-RX-API-DMAC7.html)
PT (1) PT2958903T (cg-RX-API-DMAC7.html)
RS (1) RS55932B1 (cg-RX-API-DMAC7.html)
RU (1) RU2652265C2 (cg-RX-API-DMAC7.html)
SG (1) SG11201506651SA (cg-RX-API-DMAC7.html)
SI (1) SI2958903T1 (cg-RX-API-DMAC7.html)
SM (1) SMT201700238T1 (cg-RX-API-DMAC7.html)
TN (1) TN2015000335A1 (cg-RX-API-DMAC7.html)
UA (1) UA116236C2 (cg-RX-API-DMAC7.html)
WO (1) WO2014128207A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201506050B (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2592694C2 (ru) 2010-08-18 2016-07-27 СЭМЬЮМЕД, ЭлЭлСи Дикетоны и гидроксикетоны в качестве активатора сигнального пути катенина
BR112015020391B1 (pt) 2013-02-22 2022-07-26 Samumed, Llc Gama-dicetonas como ativadoras da via de sinalização de wnt/beta-catenina
DK3206686T3 (da) 2014-08-20 2019-12-16 Samumed Llc Gamma-diketoner til behandling og forebyggelse af ældning af huden og rynker
WO2016125191A2 (en) 2015-02-04 2016-08-11 Mylan Laboratories Limited Processes for the preparation of vortioxetine hydrobromide
EP3274330A1 (en) 2015-03-26 2018-01-31 Cipla Limited Method for making serotonin reuptake inhibitors
CN106279065A (zh) * 2015-05-12 2017-01-04 北京深蓝海生物医药科技有限公司 一种氢溴酸沃替西汀的精制转晶方法
JO3456B1 (ar) 2015-05-13 2020-07-05 H Lundbeck As فيروتيوكسيتين بيروجلوتامات
CN108473451B (zh) * 2016-02-08 2022-07-15 H.隆德贝克有限公司 1-[2-(2,4-二甲基-苯基硫烷基)-苯基]哌嗪的合成
MX2018015759A (es) 2016-07-01 2019-03-21 H Lundbeck As Regimenes de dosificacion de vortioxetina para el rapido inicio del efecto antidepresivo.
US10519121B2 (en) 2016-12-30 2019-12-31 Apicore Us Llc Process and novel polymorphic form of vortioxetine and its pharmaceutically acceptable salts
EP3870292A4 (en) 2018-10-26 2022-11-09 The Research Foundation for The State University of New York COMBINATION OF SEROTONIN-SPECIFIC RESUPPUT INHIBITOR AND SEROTONIN 1A RECEPTOR PARTIAL AGONIST TO REDUCE L-DOPA-INDUCED DYSKINESIA
CN109912538B (zh) * 2019-01-22 2021-03-12 安徽赛乐普制药有限公司 一种抗抑郁药沃替西汀的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA81749C2 (uk) * 2001-10-04 2008-02-11 Х. Луннбек А/С Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну
JP2005513128A (ja) * 2001-12-20 2005-05-12 ハー・ルンドベック・アクチエゼルスカベット アリールオキシフェニル及びアリールスルファニルフェニル誘導体
MY150647A (en) * 2006-06-16 2014-02-14 Lundbeck & Co As H 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment
TW201033181A (en) * 2009-02-17 2010-09-16 Lundbeck & Co As H Purification of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine

Also Published As

Publication number Publication date
CN104995181B (zh) 2017-03-08
AU2014220735B2 (en) 2017-06-22
WO2014128207A1 (en) 2014-08-28
EA027756B1 (ru) 2017-08-31
UA116236C2 (uk) 2018-02-26
SMT201700238T1 (it) 2017-07-18
LT2958903T (lt) 2017-08-25
IL240501A0 (en) 2015-09-24
TN2015000335A1 (en) 2017-01-03
DOP2015000187A (es) 2015-11-30
CL2015002309A1 (es) 2016-03-04
ME02671B (me) 2017-06-20
ZA201506050B (en) 2017-08-30
KR20150118146A (ko) 2015-10-21
SI2958903T1 (sl) 2017-09-29
MY172337A (en) 2019-11-21
BR112015019268A2 (pt) 2020-01-28
MX362355B (es) 2019-01-14
RS55932B1 (sr) 2017-09-29
EP2958903B1 (en) 2017-04-12
US9353073B2 (en) 2016-05-31
RU2015134407A (ru) 2017-03-28
HK1216098A1 (en) 2016-10-14
PE20151589A1 (es) 2015-12-03
MX2015010656A (es) 2015-12-17
GEP201706749B (en) 2017-10-10
DK2958903T3 (en) 2017-05-15
PL2958903T3 (pl) 2017-08-31
EA201591349A1 (ru) 2015-12-30
AP2015008640A0 (en) 2015-08-31
PT2958903T (pt) 2017-05-26
RU2652265C2 (ru) 2018-04-27
HRP20170607T1 (hr) 2017-06-30
AU2014220735A1 (en) 2015-08-20
JP2016509042A (ja) 2016-03-24
CR20150423A (es) 2015-10-20
CA2901821A1 (en) 2014-08-28
MA38338A1 (fr) 2016-09-30
PH12015501807A1 (en) 2015-11-09
US20160009670A1 (en) 2016-01-14
SG11201506651SA (en) 2015-09-29
ES2625380T3 (es) 2017-07-19
CN104995181A (zh) 2015-10-21
KR102230628B1 (ko) 2021-03-22
IL240501B (en) 2018-08-30
BR112015019268B1 (pt) 2023-01-10
PH12015501807B1 (en) 2019-05-31
EP2958903A1 (en) 2015-12-30
CY1118883T1 (el) 2018-01-10
JP6464098B2 (ja) 2019-02-06

Similar Documents

Publication Publication Date Title
MA38338A1 (fr) Procédé de fabrication de vortioxétine
IL256624A (en) Pharmaceuticals and their pharmaceutical preparations for the treatment of inflammatory disorders
EA201591503A1 (ru) Производные нафтиридина, полезные в качестве антагонистов альфа-v-бета-6 интегрина
EP2970170A4 (en) PROCESS FOR PREPARING 2,5-FURANDIC ACETIC ACID
EA201891769A1 (ru) СПОСОБ ПОЛУЧЕНИЯ СОЕДИНЕНИЯ ПИРРОЛО[3,2-d]ПИРИМИДИНА И ПРОМЕЖУТОЧНЫХ СОЕДИНЕНИЙ
MY183427A (en) A method for producing 2-fluoro-4-borono-l-phenylalanine, and precursor of 2-fluoro-4-borono-l-phenylalanine
SG10201902609TA (en) Method for producing novel nitrogen-containing compound or salt thereof, and production intermediate of same
JOP20200030A1 (ar) مركب خماسي الحلقة
CY1121116T1 (el) Νεα μεθοδος για την συνθεση αγομελατινης
BR112018070345A2 (pt) processo para a preparação de derivados de 4-aminoindano e amidas de aminoindano relacionadas
MX2020009462A (es) Procesos para la preparación de compuestos de pirimidinilciclopentano.
FR3023291B1 (fr) Nouveau procede de fabrication du (e,z)-7,9 dodecandienyl-1-acetate
EA201300792A1 (ru) Химические соединения
EP3428145A4 (en) PROCESS FOR PREPARING A FLUORINATED COMPOUND
EP3492479A3 (en) Crystal of cyclic phosphonic acid sodium salt and method for manufacturing same
MX2020008488A (es) Forma cristalina del derivado de oxopicolinamida y metodo de preparacion del mismo.
EP3395815A4 (en) METHOD FOR PRODUCING A BENZOZAZOLE COMPOUND
PE20151334A1 (es) Metodo de produccion de compuestos de piridazinona
BR112014000613A2 (pt) método para a preparação de ácido ciclo-hexanocarboxílico
EP3778548A4 (en) PROCESS FOR THE PRODUCTION OF FLUORINATED ORGANIC COMPOUNDS
EA201892406A1 (ru) Способ получения гербицидных пиридинилимидазолоновых соединений
BR112018071748A2 (pt) processo para a preparação de compostos herbicidas
FR3014267B1 (fr) Procede de caracterisation d'un procede de fabrication de transistors mos
ECSP15036884A (es) Proceso de fabricación de vortioxetina
BR112018012696A2 (pt) processo aperfeiçoado para fabricação de crotonilaminopiridinas